Bupropion Hydrochloride
- Product NDC
- 68788-7479
- 11-digit product format
- 687887479
- Labeler code
- 68788
- Product ID
- 68788-7479_3da60ad2-ffe0-471e-bc26-67a58e3e50ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA207224
- Marketing category
- ANDA
- Marketing start
- 2020-03-02
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7479-1 | 68788747901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7479-1) | 2020-03-02 | 0000-00-00 | No | No | Current |
| 68788-7479-3 | 68788747903 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7479-3) | 2020-03-02 | 0000-00-00 | No | No | Current |
| 68788-7479-6 | 68788747906 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7479-6) | 2020-03-02 | 0000-00-00 | No | No | Current |
| 68788-7479-8 | 68788747908 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7479-8) | 2020-03-02 | 0000-00-00 | No | No | Current |
| 68788-7479-9 | 68788747909 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7479-9) | 2020-03-02 | 0000-00-00 | No | No | Current |